Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 35, 3735-3740, December 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kessel, D.
Right arrow Articles by Belton, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kessel, D.
Right arrow Articles by Belton, J. G.

Effects of 4-Nitrobenzofurazans and Their N-Oxides on Synthesis of Protein and Nucleic Acid by Murine Leukemia Cells1

David Kessel2 and James G. Belton

Departments of Oncology and Pharmacology, Wayne State University School of Medicine, and the Michigan Cancer Foundation, Detroit, Michigan 48201 [D. K.], and the Laboratories, Medical Research Council of Ireland, Trinity College, Dublin [J. G. B.]

A series of benzo-2,1,3-oxadiazoles (benzofurazans) and their N-oxides (benzofuroxans) inhibit incorporation of precursors into nucleic acids and protein by murine leukemia cells. At slightly higher levels, substantial single- and double-strand DNA breakage was observed. At still higher concentrations, inhibition of phosphorylation of uridine and thymidine was found. Structure-activity relationships show that only compounds bearing appropriate substitutions at positions 4 and 7 were effective inhibitors of biosynthetic pathways. Such compounds appear to interact with a wide variety of biological systems and may be useful in elucidating modes of macromolecule synthesis.

1 Supported in part by Grants CA-16053 and CA-07177 from the National Cancer Institute, NIH, and by the Irish Cancer Society.

2 To whom requests for reprints should be addressed, at Darling Memorial Center, 4160 John R Street, Detroit, Mich. 48201.

Received 3/20/75. Accepted 9/ 9/75.




This article has been cited by other articles:


Home page
J Biomol ScreenHome page
M. Honma, M. Stubbs, I. Collins, P. Workman, W. Aherne, and F. M. Watt
Identification of Novel Keratinocyte Differentiation Modulating Compounds by High-Throughput Screening
J Biomol Screen, December 1, 2006; 11(8): 977 - 984.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1975 by the American Association for Cancer Research.